Literature DB >> 20070191

The methamphetamine problem in the United States.

Rachel Gonzales1, Larissa Mooney, Richard A Rawson.   

Abstract

Significant public health problems associated with methamphetamine (MA) production and use in the United States have emerged over the past 25 years; however, there has been considerable controversy about the size of the problem. Epidemiological indicators have provided a mixed picture. National surveys of the adult U.S. population and school-based populations have consistently been used to support the position that MA use is a relatively minor concern. However, many other data sources, including law-enforcement groups, welfare agencies, substance abuse treatment program admissions, criminal justice agencies, and state/county executives indicate that MA is a very significant public health problem for many communities throughout much of the country. In this article, we describe (a) the historical underpinnings of the MA problem, (b) epidemiological trends in MA use, (c) key subgroups at risk for MA problems, (d) the health and social factors associated with MA use, (e) interventions available for addressing the MA problem, and (f) lessons learned from past efforts addressing the MA problem.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20070191      PMCID: PMC4440680          DOI: 10.1146/annurev.publhealth.012809.103600

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  88 in total

Review 1.  Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring.

Authors:  A Thomas McLellan; James R McKay; Robert Forman; John Cacciola; Jack Kemp
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

2.  Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003.

Authors:  William Wong; Janice K Chaw; Charlotte K Kent; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2005-07       Impact factor: 2.830

3.  Conversation with M. Douglas Anglin.

Authors:  M Douglas Anglin
Journal:  Addiction       Date:  2006-02       Impact factor: 6.526

4.  Male methamphetamine-user inmates in prison treatment: during-treatment outcomes.

Authors:  George W Joe; Grace A Rowan-Szal; Jack M Greener; D Dwayne Simpson; Jerry Vance
Journal:  J Subst Abuse Treat       Date:  2009-10-03

5.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study.

Authors:  J Battaglia; S Moss; J Rush; J Kang; R Mendoza; L Leedom; W Dubin; C McGlynn; L Goodman
Journal:  Am J Emerg Med       Date:  1997-07       Impact factor: 2.469

7.  Elements of well-being affected by criminalizing the drug user.

Authors:  Martin Y Iguchi; Jennifer A London; Nell Griffith Forge; Laura Hickman; Terry Fain; Kara Riehman
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

8.  Methamphetamine-related stroke: four cases.

Authors:  J A Perez; E L Arsura; S Strategos
Journal:  J Emerg Med       Date:  1999 May-Jun       Impact factor: 1.484

9.  Acute myocardial infarction in young adults who abuse amphetamines.

Authors:  Arthur N Westover; Paul A Nakonezny; Robert W Haley
Journal:  Drug Alcohol Depend       Date:  2008-03-19       Impact factor: 4.492

10.  Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment.

Authors:  Steven Shoptaw; James Peck; Cathy J Reback; Erin Rotheram-Fuller
Journal:  J Psychoactive Drugs       Date:  2003-05
View more
  110 in total

1.  Discriminative stimulus effects of NMDA, AMPA, and mGluR5 glutamate receptor ligands in methamphetamine-trained rats.

Authors:  Thomas E Wooters; Linda P Dwoskin; Michael T Bardo
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Impact of an exercise intervention on methamphetamine use outcomes post-residential treatment care.

Authors:  Richard A Rawson; Joy Chudzynski; Larissa Mooney; Rachel Gonzales; Alfonso Ang; Daniel Dickerson; Jose Penate; Bilal A Salem; Brett Dolezal; Christopher B Cooper
Journal:  Drug Alcohol Depend       Date:  2015-09-03       Impact factor: 4.492

3.  Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors.

Authors:  Mary-Lynn Brecht; Diane Herbeck
Journal:  Drug Alcohol Depend       Date:  2014-03-12       Impact factor: 4.492

4.  A genetic animal model of differential sensitivity to methamphetamine reinforcement.

Authors:  Shkelzen Shabani; Lauren K Dobbs; Matthew M Ford; Gregory P Mark; Deborah A Finn; Tamara J Phillips
Journal:  Neuropharmacology       Date:  2012-01-20       Impact factor: 5.250

Review 5.  HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.

Authors:  Peter S Silverstein; Ankit Shah; James Weemhoff; Santosh Kumar; D P Singh; Anil Kumar
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

6.  Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.

Authors:  Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

7.  Striatum and insula dysfunction during reinforcement learning differentiates abstinent and relapsed methamphetamine-dependent individuals.

Authors:  Jennifer L Stewart; Colm G Connolly; April C May; Susan F Tapert; Marc Wittmann; Martin P Paulus
Journal:  Addiction       Date:  2013-12-15       Impact factor: 6.526

8.  Post-exposure prophylaxis use and recurrent exposure to HIV among men who have sex with men who use crystal methamphetamine.

Authors:  Catherine E Oldenburg; Sachin Jain; Kenneth H Mayer; Matthew J Mimiaga
Journal:  Drug Alcohol Depend       Date:  2014-11-26       Impact factor: 4.492

9.  Androgen-primed castrate males are sufficient for methamphetamine-facilitated increases in proceptive behavior in female rats.

Authors:  Sarah A Rudzinskas; Jessica A Mong
Journal:  Horm Behav       Date:  2015-10-20       Impact factor: 3.587

10.  Dental disease patterns in methamphetamine users: Findings in a large urban sample.

Authors:  Vivek Shetty; Lauren Harrell; Debra A Murphy; Steven Vitero; Alexis Gutierrez; Thomas R Belin; Bruce A Dye; Vladimir W Spolsky
Journal:  J Am Dent Assoc       Date:  2015-12       Impact factor: 3.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.